GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (WBO:BMYS) » Definitions » Cyclically Adjusted PB Ratio

Bristol-Myers Squibb Co (WBO:BMYS) Cyclically Adjusted PB Ratio : 3.11 (As of May. 01, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio?

As of today (2024-05-01), Bristol-Myers Squibb Co's current share price is €41.635. Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €13.39. Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio for today is 3.11.

The historical rank and industry rank for Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

WBO:BMYS' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 3.04   Med: 5.84   Max: 8.86
Current: 3.04

During the past years, Bristol-Myers Squibb Co's highest Cyclically Adjusted PB Ratio was 8.86. The lowest was 3.04. And the median was 5.84.

WBO:BMYS's Cyclically Adjusted PB Ratio is ranked worse than
69.41% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.8 vs WBO:BMYS: 3.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted book value per share data for the three months ended in Mar. 2024 was €7.484. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €13.39 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.35 5.50 4.95 5.23 3.52

Bristol-Myers Squibb Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.91 4.45 3.99 3.52 3.75

Competitive Comparison of Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio falls into.



Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=41.635/13.39
=3.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bristol-Myers Squibb Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=7.484/129.4194*129.4194
=7.484

Current CPI (Mar. 2024) = 129.4194.

Bristol-Myers Squibb Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 6.804 100.560 8.757
201409 7.084 100.428 9.129
201412 7.287 99.070 9.519
201503 8.617 99.621 11.194
201506 8.081 100.684 10.387
201509 8.053 100.392 10.382
201512 7.885 99.792 10.226
201603 7.739 100.470 9.969
201606 7.946 101.688 10.113
201609 8.324 101.861 10.576
201612 9.216 101.863 11.709
201703 8.182 102.862 10.294
201706 7.977 103.349 9.989
201709 7.578 104.136 9.418
201712 6.105 104.011 7.596
201803 6.347 105.290 7.802
201806 6.461 106.317 7.865
201809 7.162 106.507 8.703
201812 7.594 105.998 9.272
201903 8.234 107.251 9.936
201906 8.683 108.070 10.398
201909 9.835 108.329 11.750
201912 20.843 108.420 24.880
202003 19.963 108.902 23.724
202006 19.342 108.767 23.015
202009 18.845 109.815 22.209
202012 13.998 109.897 16.485
202103 14.147 111.754 16.383
202106 13.748 114.631 15.522
202109 14.250 115.734 15.935
202112 14.776 117.630 16.257
202203 13.468 121.301 14.369
202206 14.445 125.017 14.954
202209 15.520 125.227 16.040
202212 14.131 125.222 14.605
202303 14.154 127.348 14.384
202306 14.127 128.729 14.203
202309 13.358 129.860 13.313
202312 13.353 129.419 13.353
202403 7.484 129.419 7.484

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bristol-Myers Squibb Co  (WBO:BMYS) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bristol-Myers Squibb Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (WBO:BMYS) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (WBO:BMYS) Headlines

No Headlines